Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYR-472 vs Alogliptin in Type 2 Diabetes
NCT01632007Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started May 2012; status: completed.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01632007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01632007.